Sign In
Markets
Lupin change gears to bring Covid-19 drugs in market; approaches Gilead for Remdesivir
Lupin share dips 2% after delayed-release of Posaconazole tablets
Pharma
Lupin reports Rs 438.3 crore net profit in Q3 FY21
Economy
Lupin launches generic immunosuppressant drug in US
